Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
die Hypomyelinisierte Leukodystrophy 2 ist eine autosomal rezessive neurologische Erkrankung, die durch Mutationen im GJC2-Gen hervorgerufen wird.
| 1. |
Uhlenberg B et al. (2004) Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. 
|
| 2. |
Wolf NI et al. (2007) Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination.
|
| 3. |
Salviati L et al. (2007) A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease.
|
| 4. |
Henneke M et al. (2008) GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.
|
| 5. |
Biancheri R et al. (2013) Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form.
|
| 6. |
Gotoh L et al. (2014) GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease.
|
| 7. |
Bugiani M et al. (2006) GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.
|
| 8. |
Henneke M et al. (2010) Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease.
|
| 9. |
Orphanet article Orphanet ID 280282
|
| 10. |
OMIM.ORG article Omim 608804
|
 |
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944 Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz |
